- Home
- CGEN vs GGR Comparison
CGEN vs GGR Comparison
Compare CGEN & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- GGR
- Stock Information
- Founded
- CGEN 1993
- GGR 2011
- Country
- CGEN Israel
- GGR Taiwan
- Employees
- CGEN N/A
- GGR N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- GGR Auto Manufacturing
- Sector
- CGEN Health Care
- GGR Consumer Discretionary
- Exchange
- CGEN Nasdaq
- GGR Nasdaq
- Market Cap
- CGEN 117.8M
- GGR 114.3M
- IPO Year
- CGEN 2000
- GGR N/A
- Fundamental
- Price
- CGEN $1.47
- GGR $0.25
- Analyst Decision
- CGEN Strong Buy
- GGR Hold
- Analyst Count
- CGEN 1
- GGR 2
- Target Price
- CGEN $4.00
- GGR $0.50
- AVG Volume (30 Days)
- CGEN 216.5K
- GGR 373.8K
- Earning Date
- CGEN 05-19-2025
- GGR 05-08-2025
- Dividend Yield
- CGEN N/A
- GGR N/A
- EPS Growth
- CGEN N/A
- GGR N/A
- EPS
- CGEN N/A
- GGR N/A
- Revenue
- CGEN $27,589,000.00
- GGR $304,551,000.00
- Revenue This Year
- CGEN $11.81
- GGR N/A
- Revenue Next Year
- CGEN $28.37
- GGR $5.00
- P/E Ratio
- CGEN N/A
- GGR N/A
- Revenue Growth
- CGEN N/A
- GGR N/A
- 52 Week Low
- CGEN $1.13
- GGR $0.19
- 52 Week High
- CGEN $2.66
- GGR $1.76
- Technical
- Relative Strength Index (RSI)
- CGEN 53.98
- GGR 42.46
- Support Level
- CGEN $1.38
- GGR $0.24
- Resistance Level
- CGEN $1.56
- GGR $0.27
- Average True Range (ATR)
- CGEN 0.08
- GGR 0.02
- MACD
- CGEN 0.02
- GGR -0.00
- Stochastic Oscillator
- CGEN 68.97
- GGR 9.09
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.